Urofollitropin action and adaptation symptoms? 【Kang Yuan】
Urofollitropin is indicated for anovulatory patients, including polycystic
ovary syndrome, who have not responded to clomiphene citrate therapy. Its
treatment aims to produce a single mature follicle, which stimulates the growth
of the follicle. It can also be used in assisted reproductive technology
ovulation-stimulated patients to stimulate the maturation of multiple follicles
in the ovary. During medication, be sure to pay attention to the ingredients
contained in this product, and patients with allergic reactions should not use
it. Patients who are pregnant or breastfeeding should not be used. Primary
ovarian failure should not be used. Undiagnosed vaginal bleeding, uterine
fibroids, and patients who are not easy to conceive are contraindicated.
The above is the relevant content summarized by the editor of Kangyuan
Company. If you want to know more, please continue to follow us. We will
regularly update you about Human chorionic gonadotropin, Human Menopausal
Gonadotropin supplier, Urofollitropin price, Urokinase manufacturer, and Hormone
API Manufacturer Related content, I hope to help you.